乳腺癌中的N2中性粒细胞和瘤进展:分子途径和影响
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Breast cancer (Dove Medical Press)
|July 28, 2025
概括
N2中性粒细胞通过帮助瘤生长,免疫逃避和扩散来促进乳腺癌. 针对这些细胞提供治疗潜力,但在特异性和临床应用方面面临挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 中性粒细胞是关键的先天性免疫细胞,在癌症中扮演着新兴的角色.
- 一个特定的子集,N2中性粒细胞,促进乳腺癌的瘤进展.
- N2 中性粒细胞有助于血管生成,免疫抑制和转移.
研究的目的:
- 审查乳腺癌中2中性粒细胞两极分化的分子机制.
- 探索瘤微环境中的N2中性粒细胞相互作用.
- 检查针对N2中性粒细胞的治疗策略.
主要方法:
- 对当前科学文献进行叙述性审查.
- 单细胞和流细胞计数据的整合.
- 分子通路的分析 (例如TGF-β,STAT3/6,低氧).
主要成果:
- 通过特定的信号通路,N2中性粒细胞表现出支持瘤的功能.
- N2中性粒细胞会产生一种免疫抑制的瘤微环境.
- 中性粒细胞可塑性和亚型差异在乳腺癌变异中很明显.
结论:
- 向N2中性粒细胞是乳腺癌的一个有希望的治疗途径.
- 挑战包括选择性向和缺乏特定的临床标志物.
- 对于有效和安全的免疫调节疗法,需要进一步的研究.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


